Association results of Genome-wide association studies (GWAS) top SNPs in the pancreatitis cohort vs healthy blood donors
Model | Additive genetic model | Recessive genetic model | ||||
---|---|---|---|---|---|---|
PVAL | OR | 95% CI | PVAL | OR | 95% CI | |
rs632111 (FUT2 GWAS lead SNP) | ||||||
Pan vs BD | 0.054 | 1.12 | 1.00 to 1.26 | 0.046 | 1.23 | 1.00 to 1.51 |
CP vs BD | 0.003 | 1.24 | 1.08 to 1.44 | 2.4×10−4 | 1.58 | 1.24 to2.02 |
AP vs BD | 0.999 | 1 | 0.86 to 1.16 | 0.469 | 0.9 | 0.68 to 1.19 |
ICP vs BD | 0.017 | 1.27 | 1.04 to 1.55 | 0.001 | 1.72 | 1.25 to 2.38 |
ACP vs BD | 0.497 | 1.08 | 0.87 to 1.34 | 0.276 | 1.23 | 0.85 to1.79 |
rs601338 (W134X SNP) | ||||||
Pan vs BD | 0.047 | 1.12 | 1.00 to 1.26 | 0.031 | 1.26 | 1.02 to 1.56 |
CP vs BD | 0.015 | 1.2 | 1.03 to 1.38 | 0.001 | 1.57 | 1.22 to 2.02 |
AP vs BD | 0.501 | 1.05 | 0.91 to 1.22 | 0.839 | 0.97 | 0.73 to 1.29 |
ICP vs BD | 0.081 | 1.2 | 0.98 to 1.46 | 0.003 | 1.7 | 1.21 to 2.37 |
ACP vs BD | 0.592 | 1.06 | 0.85 to 1.32 | 0.168 | 1.32 | 0.90 to 1.93 |
rs889512 (CTRB2 locus lead SNP) | ||||||
Pan vs BD | 0.809 | 0.9 | 0.81 to 1.18 | 0.974 | 0.99 | 0.46 to 2.12 |
CP vs BD | 0.830 | 0.98 | 0.77 to 1.23 | 0.647 | 1.23 | 0.51 to 2.99 |
AP vs BD | 0.868 | 0.98 | 0.77 to 1.24 | 0.564 | 0.73 | 0.25 to 2.19 |
ICP vs BD | 0.757 | 1.05 | 0.77 to 1.44 | 0.720 | 0.77 | 0.18 to 3.36 |
ACP vs BD | 0.073 | 0.71 | 0.48 to 1.05 | 0.902 | 0.91 | 0.21 to 3.98 |
ACP, alcoholic chronic pancreatitis; AP, acute pancreatitis; BD, blood donor cohort; CP, chronic pancreatitis; ICP, Idiopathic chronic pancreatitis; Pan, total pancreatitis cohort; PVAL, p value (χ2 test); 95% CI, 95% CI of OR, grey shaded cells are nominal significant (PVAL<0.05) yellow shaded cells are significant after Bonferroni correction for 15 tests (PVAL<0.05/15=0.003) and red shaded cells are significant after Bonferroni correction for 30 tests (PVAL<0.05/30=0.0017). Genotyping of SNPs was performed by TaqMan analysis or genomic sequencing.